The authors reply:

M. Luiza Caramori; Katherine R. Tuttle; Nikhil Tandon; David J. Tunnicliffe; Ian H. de Boer; Peter Rossing; Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group; Jonathan C. Craig

doi:10.1016/j.kint.2021.11.019

The authors reply:

M. Luiza Caramori
, Katherine R. Tuttle
, Nikhil Tandon
, David J. Tunnicliffe
, Ian H. de Boer
, Peter Rossing
, Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
, Jonathan C. Craig

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed.

Original language	English
Pages (from-to)	420-421
Number of pages	2
Journal	Kidney International
Volume	101
Issue number	2
DOIs	https://doi.org/10.1016/j.kint.2021.11.019
Publication status	Published - Feb 2022

Keywords

glycemic control
chronic kidney disease
Hemoglobin A1c
Albumin
Prognostic studies

Access to Document

10.1016/j.kint.2021.11.019Licence: In Copyright

Cite this

@article{2cfb328224a643eea3e6ab903cb544a2,

title = "The authors reply:",

abstract = "The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed. ",

keywords = "glycemic control, chronic kidney disease, Hemoglobin A1c, Albumin, Prognostic studies",

author = "Caramori, \{M. Luiza\} and Tuttle, \{Katherine R.\} and Nikhil Tandon and Tunnicliffe, \{David J.\} and \{de Boer\}, \{Ian H.\} and Peter Rossing and \{Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group\} and Chan, \{Juliana C.N.\} and Heerspink, \{Hiddo J.L.\} and Clint Hurst and Kamlesh Khunti and Adrian Liew and Michos, \{Erin D.\} and Navaneethan, \{Sankar D.\} and Olowu, \{Wasiu A.\} and Tami Sadusky and Christoph Wanner and Wilkens, \{Katy G.\} and Sophia Zoungas and Lyubov Lytvyn and Craig, \{Jonathan C.\} and Martin Howell and Marcello Tonelli and Michael Cheung and Amy Earley",

year = "2022",

month = feb,

doi = "10.1016/j.kint.2021.11.019",

language = "English",

volume = "101",

pages = "420--421",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - The authors reply:

AU - Caramori, M. Luiza

AU - Tuttle, Katherine R.

AU - Tandon, Nikhil

AU - Tunnicliffe, David J.

AU - de Boer, Ian H.

AU - Rossing, Peter

AU - Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group

AU - Chan, Juliana C.N.

AU - Heerspink, Hiddo J.L.

AU - Hurst, Clint

AU - Khunti, Kamlesh

AU - Liew, Adrian

AU - Michos, Erin D.

AU - Navaneethan, Sankar D.

AU - Olowu, Wasiu A.

AU - Sadusky, Tami

AU - Wanner, Christoph

AU - Wilkens, Katy G.

AU - Zoungas, Sophia

AU - Lytvyn, Lyubov

AU - Craig, Jonathan C.

AU - Howell, Martin

AU - Tonelli, Marcello

AU - Cheung, Michael

AU - Earley, Amy

PY - 2022/2

Y1 - 2022/2

N2 - The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed.

AB - The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed.

KW - glycemic control

KW - chronic kidney disease

KW - Hemoglobin A1c

KW - Albumin

KW - Prognostic studies

UR - https://www.scopus.com/pages/publications/85123814170

U2 - 10.1016/j.kint.2021.11.019

DO - 10.1016/j.kint.2021.11.019

M3 - Letter

C2 - 34906418

AN - SCOPUS:85123814170

SN - 0085-2538

VL - 101

SP - 420

EP - 421

JO - Kidney International

JF - Kidney International

IS - 2

ER -

The authors reply:

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this